Article Details

CHMP recommends expanded use for Alexion's PNH therapy Ultomiris

Retrieved on: 2021-07-26 09:22:30

Tags for this article:

Click the tags to see associated articles and topics

CHMP recommends expanded use for Alexion's PNH therapy Ultomiris. View article details on hiswai:

Excerpt

... of children and adolescents in Europe suffering from this devastating rare disease,” said Marc Dunoyer, incoming chief executive officer of Alexion.

Article found on: www.pharmatimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up